Merck & Co Inc (MRK)
128.27
-0.53
(-0.41%)
USD |
NYSE |
May 02, 16:00
127.76
-0.51
(-0.40%)
After-Hours: 18:49
Merck Price to Book Value: 8.646 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 8.681 |
| April 30, 2024 | 8.710 |
| April 29, 2024 | 8.770 |
| April 26, 2024 | 8.843 |
| April 25, 2024 | 8.811 |
| April 24, 2024 | 8.56 |
| April 23, 2024 | 8.552 |
| April 22, 2024 | 8.556 |
| April 19, 2024 | 8.478 |
| April 18, 2024 | 8.441 |
| April 17, 2024 | 8.450 |
| April 16, 2024 | 8.429 |
| April 15, 2024 | 8.505 |
| April 12, 2024 | 8.475 |
| April 11, 2024 | 8.503 |
| April 10, 2024 | 8.543 |
| April 09, 2024 | 8.540 |
| April 08, 2024 | 8.530 |
| April 05, 2024 | 8.627 |
| April 04, 2024 | 8.604 |
| April 03, 2024 | 8.756 |
| April 02, 2024 | 8.786 |
| April 01, 2024 | 8.829 |
| March 31, 2024 | |
| March 28, 2024 | 8.895 |
| Date | Value |
|---|---|
| March 27, 2024 | 8.881 |
| March 26, 2024 | 8.461 |
| March 25, 2024 | 8.447 |
| March 22, 2024 | 8.349 |
| March 21, 2024 | 8.333 |
| March 20, 2024 | 8.349 |
| March 19, 2024 | 8.237 |
| March 18, 2024 | 8.186 |
| March 15, 2024 | 8.192 |
| March 14, 2024 | 8.124 |
| March 13, 2024 | 8.235 |
| March 12, 2024 | 8.268 |
| March 11, 2024 | 8.276 |
| March 08, 2024 | 8.325 |
| March 07, 2024 | 8.358 |
| March 06, 2024 | 8.342 |
| March 05, 2024 | 8.280 |
| March 04, 2024 | 8.362 |
| March 01, 2024 | 8.558 |
| February 29, 2024 | 8.571 |
| February 28, 2024 | 8.639 |
| February 27, 2024 | 8.696 |
| February 26, 2024 | 8.683 |
| February 23, 2024 | 8.724 |
| February 22, 2024 | 8.711 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.866
Minimum
Feb 24 2022
8.895
Maximum
Mar 28 2024
6.651
Average
6.728
Median
Price to Book Value Benchmarks
| Amgen Inc | 23.95 |
| Johnson & Johnson | 5.154 |
| Eli Lilly and Co | 56.08 |
| Pfizer Inc | 1.757 |
| Moderna Inc | 3.473 |
Price to Book Value Related Metrics
| PE Ratio | 142.52 |
| PS Ratio | 5.311 |
| Price | 128.27 |
| Earnings Yield | 0.70% |
| Market Cap | 324.91B |
| Operating PE Ratio | 66.46 |
| Normalized PE Ratio | 105.38 |